Title Synthesis of α‐L‐fucopyranoside‐presenting glycoclusters and investigation of their interaction with recombinant Photorhabdus asymbiotica lectin (PHL)
Photorhabdus asymbiotica is a gram‐negative bacterium that is not only as effective an insect pathogen as other members of the genus, but it also causes serious diseases in humans. The recently identified lectin PHL from P. asymbiotica verifiably modulates an immune response of humans and insects, which supports the idea that the lectin might play an important role in the host‐pathogen interaction. Dimeric PHL contains up to seven L‐fucose specific binding sites per monomer, and in order to target multiple binding sites of PHL, α‐L‐fucoside‐containing di‐, tri‐ and tetravalent glycoclusters were synthesized. Methyl gallate and pentaerythritol were chosen as multivalent scaffolds, and the fucoclusters were built from the above‐mentioned cores by coupling with different oligoethylene bridges and propargyl α‐L‐fucosides using 1,3‐dipolar azide‐alkyne cycloaddition. The interaction between fucoside derivates and PHL was investigated by several biophysical and biological methods, ITC and SPR measurements, hemagglutination inhibition assay and an investigation of bacterial aggregation properties were carried out. Moreover, details of the interaction between PHL and propargyl α‐L‐fucoside as a monomer unit were revealed using X‐ray crystallography. Besides this, the interaction with multivalent compounds was studied by NMR techniques. The newly synthesized multivalent fucoclusters proved to be up to several orders of magnitude better ligands than the natural ligand, L‐fucose.
Jančaříková Gita, Mihály Herczeg, Eva Fujdiarová, Josef Houser, Katalin E. Kövér, Anikó Borbás, Michaela Wimmerová, Magdolna Csávás
Congenital myasthenic syndromes (CMS) are heterogeneous disorders in which the safety margin of neuromuscular transmission is impaired by one or more specific mechanisms. Since the advent of next‐generation sequencing methods, the discovery of novel CMS targets and phenotypes ha ... mehr
Myasthenia gravis (MG) with antibodies to muscle‐specific kinase (MuSK) is characterized by fluctuating fatigable weakness. In MuSK MG, involvement of bulbar muscles, neck, and shoulder and respiratory weakness are more prominent than in acetylcholine receptor (AChR) MG. MuSK au ... mehr
Because of the failure of many promising therapeutics identified in preclinical evaluation, funding sources have established guidelines for increased rigor in animal evaluations. The myasthenia gravis (MG) community of scientists has developed guidelines for preclinical assessme ... mehr
John Wiley & Sons, Inc. stellt die Datenbank SpecInfo erstmals über die dynamische Internet-Plattform Wiley InterScience online zur Verfügung. Mit über 434 000 regelmäßig gepflegten Einträgen gehört SpecInfo zu den weltweit größten Spektrensammlungen.
SpecInfo bietet dem Benutzer eine int ... mehr